MRK

#40
Merck & Co., Inc.
119.49 USD
-0.61%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
119.34
119.65
1年のレンジ
73.31
125.14
1日の変化
-0.61%
月次変化
+3.60%
6か月変化
+41.68%
1年の変化
+50.30%
以前の終値
120.22
始値
119.55
Bid
Ask
安値
119.34
High
119.65
ボリューム
954
チャート全体を表示

Financials

概要 明細書 統計 配当金
期次 年次
  • Market Capitalization 295.43 B
  • Employee 75 K
  • Founded N/A
  • CEO Robert M Davis
  • Website www.merck.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BPD168
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
14.46
売上高対価格比率
4.06
1株当たり配当金
3.28
配当利回り（％）
3.12

Merck & Company Inc (new)

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck".

ニュース